DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
- Status
- RECRUITING
- Phase
- PHASE3
AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- Status
- RECRUITING
- Phase
- PHASE1
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
- Status
- RECRUITING
- Phase
- NA
Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Outcome of Multiple Myeloma Associated With Autoimmune Hemolytic Anemia
- Status
- COMPLETED
- Phase
- NA
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Isa-VRD in TIE HRMM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1